Overweight Trials in Rochester, United States
Conditions / Overweight / Rochester, United States
Research into Overweight spans multiple therapeutic approaches and trial phases.
33 total trials for this combination
Showing top 10 of 33 trials
Trials
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT07037433 | Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity | RECRUITING | — |
| NCT04184622 | A Study of Tirzepatide (LY3298176) in Participants With Obesity or Overweight | COMPLETED | PHASE3 |
| NCT04100967 | Examining the Longitudinal Relationship Between Sleep and Weight Gain in College Students | COMPLETED | — |
| NCT05556512 | A Study of Tirzepatide (LY3298176) on the Reduction on Morbidity and Mortality in Adults With Obesity | ACTIVE_NOT_RECRUITING | PHASE3 |
| NCT07321886 | A Study of Eloralintide (LY3841136) in Participants With Obesity, or Overweight Without Type 2 Diabetes | RECRUITING | — |
| NCT00474630 | A Safety and Efficacy Study Comparing Naltrexone SR/Bupropion SR and Placebo in Obese Subjects With Type 2 Diabetes | COMPLETED | PHASE3 |
| NCT02019264 | A Study to Evaluate the Effect of Long-term Treatment With BELVIQ (Lorcaserin HCl) on the Incidence of Major Adverse Cardiovascular Events and Conversion to Type 2 Diabetes Mellitus in Obese and Overweight Subjects With Cardiovascular Disease or Multiple Cardiovascular Risk Factors | COMPLETED | PHASE4 |
| NCT05929066 | A Study of Retatrutide (LY3437943) in Participants Who Have Obesity or Overweight | ACTIVE_NOT_RECRUITING | PHASE3 |
| NCT01601704 | Cardiovascular Outcomes Study of Naltrexone SR/Bupropion SR in Overweight and Obese Subjects With Cardiovascular Risk Factors (The Light Study) | TERMINATED | PHASE3 |
| NCT07030868 | A Study of LY3549492 in Adults With Obesity or Overweight With Type 2 Diabetes | TERMINATED | PHASE2 |